The latest research & treatment news about Hepatitis C infection, diagnosis, symptoms and treatment.
Without pegylated interferon, experimental drugs by Bristol-Myers Squibb appear to be on the path of improving Hepatitis C treatment - by making it easier to endure and increasing the success rate.
Continue reading »Whether or not a person has metabolic syndrome, new research shows that adding fluvastatin to standard Hepatitis C combination therapy improves response rates.
Continue reading »Interim safety and efficacy data on Presidio's NS5A inhibitor, PPI-461, indicates that this novel drug could be a top Hepatitis C therapy contender.
Continue reading »What do the Epstein-Barr virus and Hepatitis C virus have in common? Not very much that will impact anyone with either condition; however, their connection could guide future research to eventually find a Hepatitis C cure.
Continue reading »The variables associated with Hepatitis B and the drugs used to treat it demonstrate that there is no single, uniform treatment strategy for addressing chronic Hepatitis B infection.
Continue reading »Australian biotech company, Biotron, concluded the first part of its Phase 2 trial evaluating BIT225, its Hepatitis C drug contender.
Continue reading »Intended to prevent the Hepatitis C virus from entering liver cells, ITX-5061 is being tested in a Phase 1b trial that could reduce liver transplant re-infection rates.
Continue reading »A large retrospective study further confirms that the IL28B genotype predicts both early and sustained responses to interferon-based Hepatitis C treatment.
Continue reading »Preliminary results from a Phase 2 trial demonstrated that 70 percent of people co-infected with Hepatitis C and HIV had undetectable levels of Hepatitis C after just four weeks of treatment with telaprevir.
Continue reading »New data about a combination of Pharmasset's developmental drugs claim a 94 percent success rate for Hepatitis C in just two weeks. Not only were these drugs highly effective in a short period of time, but they also did so without interferon.
Continue reading »Inside you'll discover:
You'll also receive the latest news and information to support liver health.
Rest assured, we will not rent your email to anyone.
You should receive your email with links to the reports shortly. If you do not, please check your spam/junk folder.
If you still haven't received our email after a few minutes, please feel free to contact us.
Close Window
